Call for Paper
Submission is open for Volume 10 Number 3 - 4 July - December 2022 Click here to submit paper
Indexing
Chairman NMA
Dr Umar Muhammad Muktar
Chairman NMA Sokoto
Abstract
| Volume 10 Number 3 - 4 July - December 2022 |
| Sale S and Dankishiya, F S |
| Background: Antidepressants are among the commonest causes of psychotropic-induced sexual dysfunction, often leading to lack of compliance, marital disharmony and poor quality of life. However, this side effect is less often explored while patients often hide their symptoms due to social norms. There is paucity of study on antidepressant-induced sexual dysfunction in northern Nigeria. Objective: This study aimed to determine patterns of sexual dysfunction among outpatients in a neuropsychiatric hospital in northern Nigeria. Methods: This was a cross- sectional study carried out in the outpatient clinic of Federal Neuropsychiatric Hospital (FNPH), Kware. Participants were men who were on antidepressants. Data was collected following informed consent using questionnaires while International Index of Erectile Function (IIEF) was used to collect data on sexual function. This was then analysed using the statistical package for social science (SPSS) version 20. Results: Eighty-seven married men aged 24-77years (mean= 40.4±14.4years) participated in this study. Their duration of illness ranged from 1-25years (median= 4.0years) while duration of treatment was 1-10years (median =2.0years). Majority had depression (78.2%) and were on tricyclic antidepressants, TCA (88.5%). The most common sexual dysfunction was orgasmic dysfunction (71.3%) followed by sexual desire (64.4%) while the least common was intercourse dissatisfaction (24.1%). Patients on selective serotonin reuptake inhibitors (SSRIs) had more sexual dysfunction than those on TCAs. Conclusion: Sexual dysfunction is common among patients receiving antidepressants. Patients on these drugs most often develop orgasmic dysfunction, loss of sexual desire and erectile dysfunction. The possibility of having sexual dysfunction should be explored in patients receiving antidepressants. |
| 10.47837/CMJ.2020814.4 |
| Download |